(Extended reading: After Tirzepatide's approval for the treatment of obesity, how long will it be before Eli Lilly's small molecule GLP-1R agonist becomes available?) Volenrelaxin (LY3540378) is a long-acting synthetic relaxin analogue that acts as an agonist for the relaxin family peptide receptor 1 (RXFP1), developed by Eli Lilly for the treatment of chronic heart failure
This is also seen in medications for depression (SSRIs), which increase serotonin to help regulate mood and are known to cause low libido and delayed/anorgasmia as well
Zhao H, Jia L, Chen G, Li X, Meng X, Zhao X, Xing L, Zhu W
cc is short for Cubic Centimeter
Gavin Creel passed away two months after being diagnosed with metastatic melanotic peripheral nerve sheath sarcoma, highlighting the aggressive nature of this rare cancer
S.XanthakisV